Literature DB >> 20724036

Association between variants in IDE-KIF11-HHEX and plasma amyloid β levels.

Christiane Reitz1, Rong Cheng, Nicole Schupf, Joseph H Lee, Pankaj D Mehta, Ekaterina Rogaeva, Peter St George-Hyslop, Richard Mayeux.   

Abstract

Genetic linkage and association studies in late-onset Alzheimer's disease (LOAD) or its endophenotypes have pointed to several regions on chromosome 10q, among these the ∼ 250 kb linkage disequilibrium (LD) block harboring the genes IDE, KIF1, and HHEX. We explored the association between variants in the genomic region harboring the IDE-KIF11-HHEX complex with plasma Aβ40 and Aβ42 levels in a case-control cohort of Caribbean Hispanics. First, we performed single marker linear regression analysis relating the individual single nucleotide polymorphisms (SNPs) with plasma Aβ40 and Aβ42 levels. Then we performed 3-SNP sliding window haplotype analyses, correcting all analyses for multiple testing. Out of 32 SNPs in this region, 3 SNPs in IDE (rs2421943, rs12264682, rs11187060) were associated with plasma Aβ40 or Aβ42 levels in single marker and haplotype analyses after correction for multiple testing. All these SNPs lie within the same LD block, and are in LD with the previously reported haplotypes. Our findings provide support for an association in the IDE region on chromosome 10q with Aβ40 and 42 levels.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20724036      PMCID: PMC3117070          DOI: 10.1016/j.neurobiolaging.2010.07.005

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  13 in total

1.  Genetic case-control association studies--correcting for multiple testing.

Authors:  D R Nyholt
Journal:  Hum Genet       Date:  2001-10-19       Impact factor: 4.132

2.  Familial Alzheimer disease among Caribbean Hispanics: a reexamination of its association with APOE.

Authors:  Stavra N Romas; Vincent Santana; Jennifer Williamson; Alejandra Ciappa; Joseph H Lee; Haydee Z Rondon; Pedro Estevez; Rafael Lantigua; Martin Medrano; Mayobanex Torres; Yaakov Stern; Benjamin Tycko; Richard Mayeux
Journal:  Arch Neurol       Date:  2002-01

3.  Degradation of soluble amyloid beta-peptides 1-40, 1-42, and the Dutch variant 1-40Q by insulin degrading enzyme from Alzheimer disease and control brains.

Authors:  A Pérez; L Morelli; J C Cresto; E M Castaño
Journal:  Neurochem Res       Date:  2000-02       Impact factor: 3.996

4.  Evidence for genetic linkage of Alzheimer's disease to chromosome 10q.

Authors:  L Bertram; D Blacker; K Mullin; D Keeney; J Jones; S Basu; S Yhu; M G McInnis; R C Go; K Vekrellis; D J Selkoe; A J Saunders; R E Tanzi
Journal:  Science       Date:  2000-12-22       Impact factor: 47.728

5.  The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics.

Authors:  M X Tang; Y Stern; K Marder; K Bell; B Gurland; R Lantigua; H Andrews; L Feng; B Tycko; R Mayeux
Journal:  JAMA       Date:  1998-03-11       Impact factor: 56.272

6.  Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death.

Authors:  Malcolm A Leissring; Wesley Farris; Alice Y Chang; Dominic M Walsh; Xining Wu; Xiaoyan Sun; Matthew P Frosch; Dennis J Selkoe
Journal:  Neuron       Date:  2003-12-18       Impact factor: 17.173

7.  Genetic variation in a haplotype block spanning IDE influences Alzheimer disease.

Authors:  Jonathan A Prince; Lars Feuk; Harvest F Gu; Boo Johansson; Margaret Gatz; Kaj Blennow; Anthony J Brookes
Journal:  Hum Mutat       Date:  2003-11       Impact factor: 4.878

8.  Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo.

Authors:  Wesley Farris; Stefan Mansourian; Yang Chang; Loren Lindsley; Elizabeth A Eckman; Matthew P Frosch; Christopher B Eckman; Rudolph E Tanzi; Dennis J Selkoe; Suzanne Guenette
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-12       Impact factor: 11.205

9.  Genetic variants in a haplotype block spanning IDE are significantly associated with plasma Abeta42 levels and risk for Alzheimer disease.

Authors:  Nilüfer Ertekin-Taner; Mariet Allen; Daniel Fadale; Leah Scanlin; Linda Younkin; Ronald C Petersen; Neill Graff-Radford; Steven G Younkin
Journal:  Hum Mutat       Date:  2004-04       Impact factor: 4.878

10.  GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers.

Authors:  Eric M Reiman; Jennifer A Webster; Amanda J Myers; John Hardy; Travis Dunckley; Victoria L Zismann; Keta D Joshipura; John V Pearson; Diane Hu-Lince; Matthew J Huentelman; David W Craig; Keith D Coon; Winnie S Liang; RiLee H Herbert; Thomas Beach; Kristen C Rohrer; Alice S Zhao; Doris Leung; Leslie Bryden; Lauren Marlowe; Mona Kaleem; Diego Mastroeni; Andrew Grover; Christopher B Heward; Rivka Ravid; Joseph Rogers; Michael L Hutton; Stacey Melquist; Ron C Petersen; Gene E Alexander; Richard J Caselli; Walter Kukull; Andreas Papassotiropoulos; Dietrich A Stephan
Journal:  Neuron       Date:  2007-06-07       Impact factor: 17.173

View more
  12 in total

1.  Alzheimer amyloid beta inhibition of Eg5/kinesin 5 reduces neurotrophin and/or transmitter receptor function.

Authors:  Csilla Ari; Sergiy I Borysov; Jiashin Wu; Jaya Padmanabhan; Huntington Potter
Journal:  Neurobiol Aging       Date:  2014-02-10       Impact factor: 4.673

2.  Candidate genes for Alzheimer's disease are associated with individual differences in plasma levels of beta amyloid peptides in adults with Down syndrome.

Authors:  Nicole Schupf; Annie Lee; Naeun Park; Lam-Ha Dang; Deborah Pang; Alexander Yale; David Kyung-Taek Oh; Sharon J Krinsky-McHale; Edmund C Jenkins; José A Luchsinger; Warren B Zigman; Wayne Silverman; Benjamin Tycko; Sergey Kisselev; Lorraine Clark; Joseph H Lee
Journal:  Neurobiol Aging       Date:  2015-06-19       Impact factor: 4.673

Review 3.  Genetics of Alzheimer's disease in Caribbean Hispanic and African American populations.

Authors:  Christiane Reitz; Richard Mayeux
Journal:  Biol Psychiatry       Date:  2013-07-25       Impact factor: 13.382

4.  NRG3 gene is associated with the risk and age at onset of Alzheimer disease.

Authors:  Ke-Sheng Wang; Nuo Xu; Liang Wang; Lorenzo Aragon; Radu Ciubuc; Tania Bedard Arana; Chunxiang Mao; Leonora Petty; David Briones; Brenda Bin Su; Xingguang Luo; Cynthia Camarillo; Michael A Escamilla; Chun Xu
Journal:  J Neural Transm (Vienna)       Date:  2013-09-24       Impact factor: 3.575

5.  A genome-wide association meta-analysis of plasma Aβ peptides concentrations in the elderly.

Authors:  V Chouraki; R F A G De Bruijn; J Chapuis; J C Bis; C Reitz; S Schraen; C A Ibrahim-Verbaas; B Grenier-Boley; C Delay; R Rogers; F Demiautte; A Mounier; A L Fitzpatrick; C Berr; J-F Dartigues; A G Uitterlinden; A Hofman; M Breteler; J T Becker; M Lathrop; N Schupf; A Alpérovitch; R Mayeux; C M van Duijn; L Buée; P Amouyel; O L Lopez; M A Ikram; C Tzourio; J-C Lambert
Journal:  Mol Psychiatry       Date:  2014-02-18       Impact factor: 15.992

6.  Whole exome sequence-based association analyses of plasma amyloid-β in African and European Americans; the Atherosclerosis Risk in Communities-Neurocognitive Study.

Authors:  Jeannette Simino; Zhiying Wang; Jan Bressler; Vincent Chouraki; Qiong Yang; Steven G Younkin; Sudha Seshadri; Myriam Fornage; Eric Boerwinkle; Thomas H Mosley
Journal:  PLoS One       Date:  2017-07-13       Impact factor: 3.240

7.  Altered expression of insulin-degrading enzyme and regulator of calcineurin in the rat intracerebral streptozotocin model and human apolipoprotein E-ε4-associated Alzheimer's disease.

Authors:  Büşra Delikkaya; Natalia Moriel; Ming Tong; Gina Gallucci; Suzanne M de la Monte
Journal:  Alzheimers Dement (Amst)       Date:  2019-05-15

8.  Genetic Risk Factors for Alzheimer's Disease in Racial/Ethnic Minority Populations in the U.S.: A Scoping Review.

Authors:  Lindsey Rubin; Lucy A Ingram; Nicholas V Resciniti; Brianna Ashford-Carroll; Katherine Henrietta Leith; Aubrey Rose; Stephanie Ureña; Quentin McCollum; Daniela B Friedman
Journal:  Front Public Health       Date:  2021-12-24

9.  Tau excess impairs mitosis and kinesin-5 function, leading to aneuploidy and cell death.

Authors:  Anne-Laure Bougé; Marie-Laure Parmentier
Journal:  Dis Model Mech       Date:  2016-01-28       Impact factor: 5.758

Review 10.  The Therapeutic Potential of Metformin in Neurodegenerative Diseases.

Authors:  Carola Rotermund; Gerrit Machetanz; Julia C Fitzgerald
Journal:  Front Endocrinol (Lausanne)       Date:  2018-07-19       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.